![Eric Hedrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Hedrick
Chief Tech/Sci/R&D Officer at
LAKEFRONT BIOTHERAPEUTICS NV
Profile
Eric E.
Hedrick is Chief Medical Officer at Lakefront Biotherapeutics since 2026.
Former roles include Chief Physician Executive at EQRx, Inc. from 2020 to 2023; Chief Medical Officer-Immuno-Oncology and Chief Medical Officer at BeOne Medicines Ltd. between 2015 and 2016; Chief Medical Officer at Epizyme, Inc. from 2012 to 2014; Interim Chief Medical Officer at Pharmacyclics LLC in 2011; and Medical Director at Genentech, Inc. in 2009.
Education includes undergraduate studies at Boston University and a doctorate from the University of Maryland.
Eric Hedrick active positions
| Companies | Position | Start |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Chief Tech/Sci/R&D Officer | 08/06/2026 |
Former positions of Eric Hedrick
| Companies | Position | End |
|---|---|---|
| EQRX, INC. | Corporate Officer/Principal | 09/11/2023 |
| BEIGENE LTD | Chief Tech/Sci/R&D Officer | 24/08/2016 |
| EPIZYME, INC. | Chief Tech/Sci/R&D Officer | 31/10/2014 |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/09/2009 |
Training of Eric Hedrick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
EQRx, Inc.
 EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
- Stock Market
- Insiders
- Eric Hedrick
